Accurate calculation of prostate-specific antigen doubling time can be crucial for prostate cancer treatment decisions but is ...

One type of cancer is on the rise in California. Experts at UCSF are finding higher rates of advanced prostate cancer, which ...

For patients with metastatic castration-resistant prostate cancer (mCRPC) unselected for homologous recombination repair (HRR ...